Hopkinton Company Holds Court For Scientists and Investors

Caliper Life Sciences, a leader of new medical research technologies
by Robert Falcione



May 17, 2011 — Caliper Life Sciences played host to over 400 scientists, investors, doctors and other pharmaceutical and medical professionals on Tuesday on the first of two days of education, inquiry and inspiration in the field of thought that disease can be diagnosed through genetic markers long before symptoms manifest themselves.
       
The viewpoint expressed by speakers today was that a new mindset of continuous care rather than reactive treatment was more beneficial for the patient as well as more cost effective in the long run, beliefs that are supported by pharmaceutical companies and academia. The mapping of the human genome and the study of the effects of genes on family history facilitate the identifying of personal biomarkers that can predict disease pre-symptomatically and establish treatment for preventative cures.
         
Caliper is involved strongly in helping shorten the time between drug trials and marketing, which makes the process more economically feasible, one for the criteria for success of a drug.
        
Above, Caliper Life Sciences CEO Kevin Hrusovsky, a Hopkinton resident, plays the part of Ron Turcotte, the jockey who rode Secretariat into the record books as the fastest thoroughbred in history. He said that after Secretariat's death, they discovered a heart that was 2.5 times the size of other horses, and said that those in the room had equally large hearts to do what they do every day in racing for cures to diseases. He also compared Secretariat's foe to cancer, something they could also beat.
          
Below is an exclusive interview with Caliper CEO Kevin Hrusovsky and with Dennis Ausiello, MD as well as clips from keynote speeches.

http://www.youtube.com/watch?v=k37TzP3FRgQ&feature=player_embedded